Novel neuroprotective strategies in ischemic retinal lesions

31Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Retinal ischemia can be effectively modeled by permanent bilateral common carotid artery occlusion, which leads to chronic hypoperfusion-induced degeneration in the entire rat retina. The complex pathways leading to retinal cell death offer a complex approach of neuroprotective strategies. In the present review we summarize recent findings with different neuroprotective candidate molecules. We describe the protective effects of intravitreal treatment with: (i) urocortin 2; (ii) a mitochondrial ATP-sensitive K + channel opener, diazoxide; (iii) a neurotrophic factor, pituitary adenylate cyclase activating polypeptide; and (iv) a novel poly(ADP-ribose) polymerase inhibitor (HO3089). The retinoprotective effects are demonstrated with morphological description and effects on apoptotic pathways using molecular biological techniques. © 2010 by the authors; licensee Molecular Diversity Preservation International.

Cite

CITATION STYLE

APA

Szabadfi, K., Mester, L., Reglodi, D., Kiss, P., Babai, N., Racz, B., … Atlasz, T. (2010, February). Novel neuroprotective strategies in ischemic retinal lesions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms11020544

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free